Product Update Coloplast Limited Wellead Range of Self-Retaining Catheter (Foley) 2-Way Silicone (ICN 3312)

• Coloplast Limited informed us that its Wellead range of self‑retaining (Foley) 2‑way silicone catheters are to be discontinued.
• Five products have now been delisted from our online catalogue:
  • FUS85139, FUS85142, FUS85140, FUS85138 and FUS85137.
• FUS85141 and FUS85136 remain available while our remaining stocks last and will then be delisted.
• The Folysil range will remain available and are listed as indirect alternatives for the affected products in our online catalogue.
• This ICN is now closed.

Change:

• The supplier Coloplast Limited has informed us of a discontinuation with its Wellead Range of self-retaining catheter (Foley) 2-way silicone products.
• There are seven product codes affected.
• Wellead male 2‑way catheters were introduced in 2024 as a temporary replacement during Folysil supply issues, which led to Folysil products suspension from the framework in 2025.
• Following improvements, Coloplast has restored sustainable Folysil supply, and these products have been reinstated on the framework.
• To avoid duplication, the Wellead range will be delisted from 1 May 2026, with Folysil remaining as the sole option.

Impact:          

• FSU85136 and FSU85141 are available while our remaining stock lasts before being delisted from our online catalogue.
• The remaining product codes will be delisted on 1 May 2026.
• Potential indirect alternative products are available to order through our online catalogue.
• See ‘Indirect Alternatives 1’ in the product listing for the equivalent Folysil alternatives to the affected codes to support customers during this transition.
• Our online catalogue is in the process of being updated to reflect the product listing.
• See our Downloads ▼ section to access the product listing below for further information on the affected product codes and potential alternatives.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.